IR Information
Presentation Materials for Management Presentation on Feb 27 2026 with Script
(Amendment) Notice Regarding Amendment to “Notice Regarding Commencement of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)” and Public Notice of Commencementof Tender Offer Dueto Filingof Amendment Statement
Notice of Formulation of Management Plan “Mission 2030” Phase 2 (FY2026–FY2028)
Presentation Material for Management Presentation on Feb 27th 2026
Notice of Commencement of Consideration of Spin-off of Styrene-Related Businesses
News
First-time Selection as an Environmentally Sustainable Company at the ESG Finance Awards Japan
FY2025 Third Quarter Financial Results Presentation Summary of Q&A Session
This website uses cookies to ensure that you use this website comfortably. If you continue to browse this website, you will agree to the use of our cookies.